Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer
Abstract Methylation alterations of specific genes have recently been identified as diagnostic biomarkers for human cancers. Although MEG3 has been proved to be a tumor suppressor in cervical cancer according to our previous study, the diagnostic value of MEG3 methylation in plasma is still unknown....
Guardado en:
Autores principales: | Jun Zhang, Tingting Yao, Zhongqiu Lin, Yali Gao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78870cd80ff04119a01a8e50d2580630 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia.
por: Chi-Yu Lai, et al.
Publicado: (2011) -
MEG source localization using invariance of noise space.
por: Junpeng Zhang, et al.
Publicado: (2013) -
Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis
por: Lars Erichsen, et al.
Publicado: (2018) -
Automatic inhibitory function in the human somatosensory and motor cortices: An MEG-MRS study
por: Chia-Hsiung Cheng, et al.
Publicado: (2017) -
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.
por: Victoria Gonzalo, et al.
Publicado: (2010)